Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Michael Cuccione Childhood Cancer Research Program, B.C. Children's Hospital Research Institute, Vancouver, BC, Canada.
Prog Mol Subcell Biol. 2021;59:181-196. doi: 10.1007/978-3-030-67696-4_9.
The lectin chaperones calreticulin (CALR) and calnexin (CANX), together with their co-chaperone PDIA3, are increasingly implicated in studies of human cancers in roles that extend beyond their primary function as quality control facilitators of protein folding within the endoplasmic reticulum (ER). Led by the discovery that cell surface CALR functions as an immunogen that promotes anti-tumour immunity, studies have now expanded to include their potential uses as prognostic markers for cancers, and in regulation of oncogenic signaling that regulate such diverse processes including integrin-dependent cell adhesion and migration, proliferation, cell death and chemotherapeutic resistance. The diversity stems from the increasing recognition that these proteins have an equally diverse spectrum of subcellular and extracellular localization, and which are aberrantly expressed in tumour cells. This review describes key foundational discoveries and highlight recent findings that further our understanding of the plethora of activities mediated by CALR, CANX and PDIA3.
凝集素伴侣蛋白 calreticulin(CALR)和 calnexin(CANX),以及它们的共同伴侣蛋白 PDIA3,在人类癌症研究中的作用越来越受到关注,其作用超出了它们在内质网(ER)内作为蛋白质折叠质量控制促进因子的主要功能。最初的发现表明,细胞表面的 CALR 作为一种免疫原,促进抗肿瘤免疫,现在的研究已经扩展到包括它们作为癌症预后标志物的潜在用途,以及调节致癌信号,调节包括整合素依赖性细胞黏附和迁移、增殖、细胞死亡和化疗耐药在内的多种过程。这种多样性源于人们越来越认识到这些蛋白质在亚细胞和细胞外定位上具有同样多样化的特征,并且在肿瘤细胞中异常表达。这篇综述描述了关键的基础发现,并强调了最近的发现,这些发现进一步加深了我们对 CALR、CANX 和 PDIA3 介导的多种活性的理解。